Longhini, Federico
Bruni, Andrea
Garofalo, Eugenio
Ronco, Chiara
Gusmano, Andrea
Cammarota, Gianmaria
Pasin, Laura
Frigerio, Pamela
Chiumello, Davide
Navalesi, Paolo http://orcid.org/0000-0002-3733-3453
Article History
Received: 22 April 2020
Accepted: 22 July 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: The study was approved by the local Ethics Committees of Alessandria, Italy (Approval number AslVc.Rian.14.03, on 11th September 2014). Written informed consent was obtained from each participant before inclusion in the study, according to the local regulations and principles outlined in the Helsinki Declaration.
: All patients gave consent for data publication according to national regulations. All authors read the final manuscript and approved the submitted version.
: Dr. Navalesi’s research laboratory has received equipment and grants from Maquet Critical Care, Draeger, and Intersurgical S.p.A. He also received honoraria/speaking fees from Maquet Critical Care, Orionpharma, Philips, Resmed, MSD, and Novartis. Dr. Navalesi contributed to the development of the helmet Next, whose licence for patent belongs to Intersurgical S.P.A., and receives royalties for that invention. Dr. Longhini and Dr. Navalesi contributed to the development of a new device (not discussed in the present study), whose patent is in progress (European Patent application number EP20170199831). The remaining authors have no conflict of interest to disclose.